Leaders: Phil Marshall, co-founder and chief product officer; West Shell III, co-founder and CEO
Conversa raised $8 million Series A in 2017 for its healthcare conversation platform. The company is working to deliver an easy and meaningful way for care teams and patients to communicate. Conversa has an extensive library of over 50 clinically-intelligent conversation programs that include asthma, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), diabetes, hypertension, joint replacement, and many more. Conversa says using its AI technology, healthcare organizations can deliver automated, personalized doctor/patient conversation experiences that lead to more informed and meaningful patient relationships, efficient population management and, ultimately, better clinical and financial outcomes.